Hematocrit, Blood Donation, and Safety on TRT

Testosterone stimulates erythropoiesis — red blood cell production in the bone marrow. This is actually one of TRT's therapeutic effects (it's why TRT can help with anemia). However, excessive RBC production thickens the blood (polycythemia), increasing the risk of blood clots, stroke, and cardiovascular events. Hematocrit is the percentage of blood volume made up of red blood cells. Normal male range: 38.5-50%. On TRT, many men see HCT rise to 48-52%. Above 52%, most clinicians recommend intervention. Above 54%, risk increases significantly. This is the single most important safety parameter to monitor on TRT.

Step 1: Verify it's real. Dehydration falsely elevates hematocrit — drink 1L of water before your blood draw. Step 2: Lower your dose. The dose-response relationship for erythropoiesis is strong — even a 20mg/week reduction can lower HCT. Step 3: Increase injection frequency. More frequent, smaller injections produce less erythropoietic stimulus than one large weekly bolus. Step 4: Therapeutic phlebotomy (blood donation). One unit (500mL) typically drops HCT by 3-4%. Step 5: Daily low-dose aspirin (81mg) for cardiovascular protection if HCT is persistently elevated (discuss with your doctor). Step 6: Address sleep apnea — untreated sleep apnea independently raises HCT and amplifies TRT's erythropoietic effect. If you snore, get a sleep study.

If you donate through regular blood banks: most allow donation if HCT is below a certain threshold, TRT is not a disqualifier for most blood banks, tell them you're on TRT (it doesn't affect donation eligibility), and therapeutic phlebotomy is different from donation — donated blood can't be used. Some clinics offer in-office therapeutic phlebotomy. Frequency: some men donate every 8-12 weeks, others every 3-4 months, and some never need it. Don't donate on a schedule — donate when your labs indicate you need to, typically when HCT exceeds 52%. Excessive donation risks crashing ferritin (iron stores), leading to fatigue, hair loss, and other issues. Always monitor ferritin alongside HCT.

The 'TRT causes heart attacks' narrative is largely based on one flawed 2013 study that was later heavily criticized and partially retracted. Modern evidence shows: TRT in men with true hypogonadism is generally cardiovascularly neutral or possibly protective. Normalizing testosterone improves insulin sensitivity, reduces body fat, and increases lean mass — all cardioprotective. The primary cardiovascular risk from TRT is elevated hematocrit and possibly worsened sleep apnea. Supraphysiological dosing (bodybuilder-level T) does carry increased cardiovascular risk. The dose makes the poison — keep your T in the physiological range, monitor HCT, and address sleep apnea.